anesthesia
Conditions
Interventions
study group:4ml of 2% lidocaine paracervical block combind with intravenous oxycodone hydrochloride
control Group:intravenous oxycodone hydrochloride
Sponsors
The Third Hospital of Hebei Medical University
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) Uterine adenomyosis clinically diagnosed using magnetic resonance imaging or ultrasonography; 2) tumor =3 cm on ultrasound examination located in a safe ultrasound channel; 3) indication for surgery but refusal of surgical or medical treatment or drug therapy failure; 4) tumor symptoms and no indication for surgery; 5) presence of uterine fibroids and the desire to bear children; 6) having =3 cm thick monolayer muscle wall in adenomyosis.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1) Critical systemic condition (patients with serious cardiac, cerebral, or kidney diseases); 2) pelvic diseases, including malignancy, endometriosis, ovarian tumors, and acute pelvic diseases; 3) collagen connective tissue diseases; 4) a history of radiation therapy in low abdome ; 5) clinically suspected sarcomas; 6) surgical scarring or clipping in HIFU beam path; 7) could not maintained prone position for at least 1 h; 8) use of other sedatives or analgesics; 9) allergic to anesthesia, with mental illness, or excluded by the investigator for any other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score;respiration;ECG;SPO2;artery blood pressure; facial expression;bladder or rectum irritation symptoms during and after treatment;patients feeling after HIFU treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| dose and suage of oxycodone hydrochloride; local anesthesia induced adverse reaction; | — |
Countries
China
Contacts
Public ContactZhao Senming
Department of Painology, The Third Hospital of Hebei Medical University
Outcome results
None listed